US/Global

  • Booster May Up Antibodies in Patients With Cancer When Standard Dose Fails

    Medscape -

    Lauren Shapiro, M.D., and Astha Thakkar, M.B.B.S., discuss their study that found that most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 developed antibodies following a booster shot. Drs. Shapiro and Thakkar are third-year hematology/oncology fellows at Albert Einstein College of Medicine and Montefiore Medical Center.

    Additional Coverage includes UPI, U.S. News & World Report (via HealthDay), MedPage Today

  • Her Husband Died by Suicide. She Sued His Pain Doctors

    STAT News -

    Joanna Starrels, M.D., M.S., explains that awareness is increasing among providers that there are risks associated with suddenly or significantly reducing a patient's opioid dose. She notes, however, that research is needed to identify and appropriately treat those at high risk for withdrawal symptoms, increased pain, serious psychological distress, and suicidal thoughts. Dr. Starrels is associate professor of medicine at Einstein and an internist and addiction medicine specialist at Montefiore.

  • Albert Einstein Cancer Center

    BronxNet -

    Ulrich Steidl, M.D., Ph.D., talks about his NCI Outstanding Investigator Award and $7 million grant that will support his research on the molecular and cellular mechanisms underlying myelodysplastic syndromes and acute myeloid leukemia. Dr. Steidl is co-director of the Blood Cancer Institute and associate director of basic science at the Albert Einstein Cancer Center, and professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Einstein.

Research Publications

Community Publications